In Vitro Diagnostics (IVD) Market - Global Industry Analysis

In Vitro Diagnostics (IVD) Market By Product & Service (Reagents, Instruments, and Software & Services), By Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, and Clinical Chemistry), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 21-Mar-2022 Category: Healthcare Report Format : PDF Pages: 150 Report Code: ZMR-130 Status : Published

The global in vitro diagnostics (IVD) market was valued at $98.3 billion in 2021 and is anticipated to reach $113.2 billion by the end of 2028. The market is projected to grow with a healthy CAGR of 2.9% during the forecast period.

Description

Industry Perspective:

The global in vitro diagnostics (IVD) market was valued at $98.3 billion in 2021 and is anticipated to reach $113.2 billion by the end of 2028. The market is projected to grow with a healthy CAGR of 2.9% during the forecast period. The report is a comprehensive study of market definition, growth drivers, opportunities, and challenges. It offers both quantitative and qualitative insights into the global market dynamics.

In Vitro Diagnostics (IVD) Market: Overview

In vitro diagnostic refers to the medical devices that need the help of reagents and assays to diagnose a medical condition. However, these instruments analyze the tissue samples and body fluids collected from patients. These diagnostic systems are widely adopted to execute different in-vitro tests on targeted samples. These are used to diagnose different health conditions like cancer and diabetes. They also monitor different infectious and autoimmune diseases.

COVID-19 Impact:

The outbreak of the Covid-19 pandemic has positively impacted the growth of the global in vitro diagnostics (IVD) market. Due to the severely growing cases of coronavirus, there was high demand for immunodiagnostics and molecular testing, which led to an increase in the sales of these diagnostic kits. There was a significant spike in the volume of point of care testing during the pandemic owing to its capability to do a faster on-site screening. During the pandemic period, several new startups emerged in the market due to the growing scope of in vitro diagnostic kits. On the contrary, the pandemic has also decreased the demand for in-vitro diagnoses used in autoimmune, nephrology, oncology, and cardiology disorders. This footfall in clinics and healthcare centers led to the decline in the global market. However, with the mixed impact of the Covid-19 on the global market, the market is likely to witness strong growth prospects in the forthcoming years in the global market.

In Vitro Diagnostics (IVD) Market: Growth Drivers

Rapid shift to point-of-care testing is likely to boost the growth of the global market.

The traditional model of laboratory testing all across the globe was a centralized laboratory that utilized automatic analytical testing techniques to detect the target. However, this one was well established in metallurgy discipline & clinical chemistry and is now extending to other spaces also. Point-of-care devices over conventional procedures offer ease of use affordability and yield rapid results that are high in demand for initiating quick decision making. However, the high adoption rate of POC devices is largely impacted by the need to make the healthcare system more patient-centric. Centralized testing does not offer a convenient process in respect of patients as the testing process is not connected with consultations calls. However, it poses a huge drawback for patients with chronic diseases like diabetes that need constant monitoring. Apart from this, the world is witnessing growing incidences of chronic diseases. Parallelly, there is a rise in awareness among people regarding the early diagnosis and proper treatment, which in turn is further expanding the scope of the global in vitro diagnostics (IVD) market. People became more aware of the availability of advanced novel IVD products.

Global In Vitro Diagnostics (IVD) Market

In Vitro Diagnostics (IVD) Market: Restraints

High cost of IVD instruments is likely to hamper the growth of the global market.

In-vitro diagnostics are quite expensive when compared to other available technology. It also requires constant maintenance of instruments which is further likely to hamper the growth of the global market. Additionally, such instruments also need skilled professionals to operate, thereby limiting its growth.

In Vitro Diagnostics (IVD) Market: Opportunities

The high adoption rate of point of care testing devices is likely to create several lucrative growth opportunities in the global market.

Medical device companies are constantly increasing their research and development capabilities to innovate technologically advanced diagnostic devices. Hospitals and laboratories have shown high interest in the point of care testing devices to collect precise real-time data. Such an increase in interest in point-of-care testing devices is due to the constantly growing burden of diseases on healthcare infrastructure, which requires advanced results in a short period of time. Therefore, such a landscape is likely to offer ample impetus to the growth of the global market in the forthcoming years.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

In Vitro Diagnostics (IVD) Market: Challenges

Unfavorable reimbursement landscape is a huge challenge in the global market.

The lack of a proper financing system will hamper the growth of the global market. Advanced treatment is quite expensive, and therefore it restricts people from undergoing treatment through in vitro diagnostics, thereby posing a huge challenge in the global market.

In Vitro Diagnostics (IVD) Market: Segmentation

The global in vitro diagnostics (IVD) market can be segmented into product & service, technique, and region.

By product & service, the market can be segmented into software & services, instrument, and reagents. 

By technique, the market can be segmented into clinical chemistry, tissue diagnostics, molecular diagnostics, hematology, and immunodiagnostics.

Recent Developments

  • Sysmex Corporation, in January 2021, partnered with Roche Diagnostics (Switzerland) to optimize its strengths like competitive products, extensive sales, and service networks.
  • Abbott Laboratories in September 2021 got US FDA has clearance for the Freestyle libre 2 iOS application for its utilization with compatible iPhones.

In Vitro Diagnostics (IVD) Market: Regional Landscape

North America accounts for the largest share in the global in vitro diagnostics (IVD) market due to the presence of a robust healthcare system in the region. Furthermore, the high awareness among people in the region regarding the presence of such advanced novel technology is likely to boost the growth of the regional market. Additionally, the efficient reimbursement policies implemented by the government will further encourage people to adopt such advanced technology to undergo a complete treatment for different diseases, which in turn will accentuate the growth of the regional market.

In Vitro Diagnostics (IVD) Market: Competitive Landscape

Some of the significant players in the global in vitro diagnostics (IVD) market include QIAGEN N.V., Ortho Clinical Diagnostics, DiaSorin, bioMérieux, Sysmex Corporation, Bio-Rad Laboratories, Becton, Dickinson and Company, Johnson & Johnson, Thermo Fisher Scientific, Danaher Corporation, Siemens Healthineers, and Roche Diagnostics.

Global in vitro diagnostics (IVD) market is segmented as follows:

By Product & Service

  • Reagents
  • Instruments
  • Software and Services

By Technique

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. In-Vitro Cancer Diagnostics Market, 2016 - 2026, (USD Million)
    • 2.2. In-Vitro Cancer Diagnostics Market: Snapshot
  • Chapter 3. Global In-Vitro Cancer Diagnostics Market – Industry Analysis
    • 3.1. In-Vitro Cancer Diagnostics Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rising incidences of chronic lifestyle diseases across the globe
      • 3.2.2. Growing aging population, and increasing usage of point-of-care testing and personalized medicine
    • 3.3. Restraints
      • 3.3.1. Inadequate returning pulicy and stringent regulatory approval framework
    • 3.4. Opportunity
      • 3.4.1. Ongoing research and development in the healthcare sector coupled with advancement in medical technulogies
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Product segment
      • 3.6.2. Market attractiveness analysis by Technology segment
      • 3.6.3. Market attractiveness analysis by Application segment
      • 3.6.4. Market attractiveness analysis by regional segment
  • Chapter 4. Global In-Vitro Cancer Diagnostics Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global In-Vitro Cancer Diagnostics market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Technology launches
      • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global In-Vitro Cancer Diagnostics Market – product Segment Analysis
    • 5.1. Global In-Vitro Cancer Diagnostics market overview: by Product
      • 5.1.1. Global In-Vitro Cancer Diagnostics market revenue share, by Product, 2019 and 2026
    • 5.2. Instruments
      • 5.2.1. Global In-Vitro Cancer Diagnostics market by Instruments, 2016-2026 (USD Million)
    • 5.3. Reagents and Kits
      • 5.3.1. Global In-Vitro Cancer Diagnostics market by Reagents and Kits, 2016-2026 (USD Million)
    • 5.4. Data Management System/Software
      • 5.4.1. Global In-Vitro Cancer Diagnostics market by Data Management System/Software, 2016-2026 (USD Million)
    • 5.5. Services
      • 5.5.1. Global In-Vitro Cancer Diagnostics market by Services, 2016-2026 (USD Million)
  • Chapter 6. Global In-Vitro Cancer Diagnostics Market – Technology Segment Analysis
    • 6.1. Global In-Vitro Cancer Diagnostics market overview: by Technology
      • 6.1.1. Global In-Vitro Cancer Diagnostics market revenue share, by Technology, 2019 and 2026
    • 6.2. Clinical Chemistry
      • 6.2.1. Global In-Vitro Cancer Diagnostics market by Clinical Chemistry, 2016-2026 (USD Million)
    • 6.3. Immunochemistry/Immunoassays
      • 6.3.1. Global In-Vitro Cancer Diagnostics market by Immunochemistry/Immunoassays, 2016-2026 (USD Million)
    • 6.4. Hematulogy
      • 6.4.1. Global In-Vitro Cancer Diagnostics market by Hematulogy, 2016-2026 (USD Million)
    • 6.5. Coagulation and Hemostasis
      • 6.5.1. Global In-Vitro Cancer Diagnostics market by Coagulation and Hemostasis, 2016-2026 (USD Million)
    • 6.6. Microbiulogy
      • 6.6.1. Global In-Vitro Cancer Diagnostics market by Microbiulogy, 2016-2026 (USD Million)
    • 6.7. Molecular Diagnostics
      • 6.7.1. Global In-Vitro Cancer Diagnostics market by Molecular Diagnostics, 2016-2026 (USD Million)
    • 6.8. Other IVD Technologies
      • 6.8.1. Global In-Vitro Cancer Diagnostics market by Other IVD Technologies, 2016-2026 (USD Million)
  • Chapter 7. Global In-Vitro Cancer Diagnostics Market – Application Segment Analysis
    • 7.1. Global In-Vitro Cancer Diagnostics market overview: by Application
      • 7.1.1. Global In-Vitro Cancer Diagnostics market revenue share, by Application, 2019 and 2026
    • 7.2. Laboratories
      • 7.2.1. Global In-Vitro Cancer Diagnostics market by Laboratories, 2016-2026 (USD Million)
    • 7.3. Hospitals
      • 7.3.1. Global In-Vitro Cancer Diagnostics market by Hospitals, 2016-2026 (USD Million)
    • 7.4. Academic Institutes
      • 7.4.1. Global In-Vitro Cancer Diagnostics market by Academic Institutes, 2016-2026 (USD Million)
    • 7.5. Point-of-care Testing
      • 7.5.1. Global In-Vitro Cancer Diagnostics market by Point-of-care Testing, 2016-2026 (USD Million)
    • 7.6. Patient Self-testing
      • 7.6.1. Global In-Vitro Cancer Diagnostics market by Patient Self-testing, 2016-2026 (USD Million)
    • 7.7. Other End Users
      • 7.7.1. Global In-Vitro Cancer Diagnostics market by Other End Users, 2016-2026 (USD Million)
  • Chapter 8. Global In-Vitro Cancer Diagnostics Market - Regional Analysis
    • 8.1. Global In-Vitro Cancer Diagnostics market overview: by region
      • 8.1.1. Global In-Vitro Cancer Diagnostics market revenue share, by region, 2019 and 2026
    • 8.2. North America
      • 8.2.1. North America In-Vitro Cancer Diagnostics market, by country, 2016-2026 (USD Million)
      • 8.2.2. North America In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
      • 8.2.3. North America In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
      • 8.2.4. North America In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S. In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
        • 8.2.5.2. The U.S. In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
        • 8.2.5.3. The U.S. In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
        • 8.2.6.2. Rest of North America In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
        • 8.2.6.3. Rest of North America In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe In-Vitro Cancer Diagnostics market, by country, 2016-2026 (USD Million)
      • 8.3.2. Europe In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
      • 8.3.3. Europe In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
      • 8.3.4. Europe In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
      • 8.3.5. U.K.
        • 8.3.5.1. U.K. In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
        • 8.3.5.2. U.K. In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
        • 8.3.5.3. U.K. In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
        • 8.3.6.2. France In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
        • 8.3.6.3. France In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
        • 8.3.7.2. Germany In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
        • 8.3.7.3. Germany In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
        • 8.3.8.2. Rest of Europe In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
        • 8.3.8.3. Rest of Europe In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific In-Vitro Cancer Diagnostics market, by country, 2016-2026 (USD Million)
      • 8.4.2. Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
      • 8.4.3. Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
      • 8.4.4. Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
        • 8.4.5.2. China In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
        • 8.4.5.3. China In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
        • 8.4.6.2. Japan In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
        • 8.4.6.3. Japan In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
        • 8.4.7.2. India In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
        • 8.4.7.3. India In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America In-Vitro Cancer Diagnostics market, by country, 2016-2026 (USD Million)
      • 8.5.2. Latin America In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
      • 8.5.3. Latin America In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
      • 8.5.4. Latin America In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
        • 8.5.5.2. Brazil In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
        • 8.5.5.3. Brazil In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
        • 8.5.6.2. Rest of Latin America In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
        • 8.5.6.3. Rest of Latin America In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
    • 8.6. Middle East & Africa
      • 8.6.1. Middle East & Africa In-Vitro Cancer Diagnostics market, 2016-2026 (USD Million)
      • 8.6.2. Middle East & Africa In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
      • 8.6.3. Middle East & Africa In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
      • 8.6.4. Middle East & Africa In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. Roche Diagnostics.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Abbott Laboratories
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Becton, Dickson and Company
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Ortho-Clinical Diagnostics
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Johnson and Johnson
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. Danaher Corporation
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. Thermo Fisher Scientific
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. Siemens Healthcare
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. Bio-Rad Laboratories, Inc
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments
    • 9.10. Sysmex Corporation
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global In-Vitro Cancer Diagnostics market, 2016-2026 (USD Million)
4. Porter’s five forces analysis: In-Vitro Cancer Diagnostics market
5. Global In-Vitro Cancer Diagnostics market attractiveness, by Product
6. Global In-Vitro Cancer Diagnostics market attractiveness, by Technology
7. Global In-Vitro Cancer Diagnostics market attractiveness, by Application
8. Global In-Vitro Cancer Diagnostics market revenue share, by Product, 2019 and 2026
9. Global In-Vitro Cancer Diagnostics market by Instruments, 2016-2026 (USD Million)
10. Global In-Vitro Cancer Diagnostics market by Reagents and Kits, 2016-2026 (USD Million)
11. Global In-Vitro Cancer Diagnostics market by Data Management System/Software, 2016-2026 (USD Million)
12. Global In-Vitro Cancer Diagnostics market by Services, 2016-2026 (USD Million)
13. Global In-Vitro Cancer Diagnostics market revenue share, by Technology, 2019 and 2026
14. Global In-Vitro Cancer Diagnostics market by Clinical Chemistry, 2016-2026 (USD Million)
15. Global In-Vitro Cancer Diagnostics market by Immunochemistry/Immunoassays, 2016-2026 (USD Million)
16. Global In-Vitro Cancer Diagnostics market by Hematology, 2016-2026 (USD Million)
17. Global In-Vitro Cancer Diagnostics market by Coagulation and Hemostasis, 2016-2026 (USD Million)
18. Global In-Vitro Cancer Diagnostics market by Microbiology, 2016-2026 (USD Million)
19. Global In-Vitro Cancer Diagnostics market by Molecular Diagnostics, 2016-2026 (USD Million)
20. Global In-Vitro Cancer Diagnostics market by Other IVD Technologies, 2016-2026 (USD Million)
21. Global In-Vitro Cancer Diagnostics market revenue share, by Application, 2019 and 2026
22. Global In-Vitro Cancer Diagnostics market by Laboratories, 2016-2026 (USD Million)
23. Global In-Vitro Cancer Diagnostics market by Hospitals, 2016-2026 (USD Million)
24. Global In-Vitro Cancer Diagnostics market by Academic Institutes, 2016-2026 (USD Million)
25. Global In-Vitro Cancer Diagnostics market by Point-of-care Testing, 2016-2026 (USD Million)
26. Global In-Vitro Cancer Diagnostics market by Patient Self-testing, 2016-2026 (USD Million)
27. Global In-Vitro Cancer Diagnostics market by Other End Users, 2016-2026 (USD Million)
28. Global In-Vitro Cancer Diagnostics market revenue share, by region, 2018 & 2025
29. North America In-Vitro Cancer Diagnostics market, 2016-2026 (USD Million)
30. Europe In-Vitro Cancer Diagnostics market, 2016-2026 (USD Million)
31. Asia Pacific In-Vitro Cancer Diagnostics market, 2016-2026 (USD Million)
32. Latin America In-Vitro Cancer Diagnostics market, 2016-2026 (USD Million)
33. Middle East & Africa In-Vitro Cancer Diagnostics market, 2016-2026 (USD Million)


Table Of Tables

List of Tables

1. Global In-Vitro Cancer Diagnostics market: snapshot
2. Drivers for In-Vitro Cancer Diagnostics market: impact analysis
3. Restraints for In-Vitro Cancer Diagnostics market: impact analysis
4. North America In-Vitro Cancer Diagnostics market revenue, by country, 2016-2026 (USD Million)
5. North America In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
6. North America In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
7. North America In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
8. The U.S. In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
9. The U.S. In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
10. The U.S. In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
11. Rest of North America In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
12. Rest of North America In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
13. Rest of North America In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
14. Europe In-Vitro Cancer Diagnostics market revenue, by country, 2016-2026 (USD Million)
15. Europe In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
16. Europe In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
17. Europe In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
18. U.K. In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
19. U.K. In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
20. U.K. In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
21. France In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
22. France In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
23. France In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
24. Germany In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
25. Germany In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
26. Germany In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
27. Rest of Europe In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
28. Rest of Europe In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
29. Rest of Europe In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
30. Asia Pacific In-Vitro Cancer Diagnostics market revenue, by country, 2016-2026 (USD Million)
31. Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
32. Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
33. Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
34. China In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
35. China In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
36. China In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
37. Japan In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
38. Japan In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
39. Japan In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
40. India In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
41. India In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
42. India In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
43. Rest of Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
44. Rest of Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
45. Rest of Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
46. Latin America In-Vitro Cancer Diagnostics market revenue, by country, 2016-2026 (USD Million)
47. Latin America In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
48. Latin America In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
49. Latin America In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
50. Brazil In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
51. Brazil In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
52. Brazil In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
53. Rest of Latin America In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
54. Rest of Latin America In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
55. Rest of Latin America In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
56. Middle East & Africa In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
57. Middle East & Africa In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
58. Middle East & Africa In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)


 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The traditional model of laboratory testing all across the globe was a centralized laboratory that utilized automatic analytical testing techniques to detect the target. However, this one was well established in metallurgy discipline and clinical chemistry and is now extending to other spaces also. Parallelly, there is a rise in awareness among people regarding the early diagnosis and proper treatment, which in turn is further expanding the scope of the global in (IVD) market.

The global in vitro diagnostics (IVD) market was valued at $98.3 billion in 2021 and is anticipated to reach $113.2 billion by the end of 2028. The market is projected to grow with a healthy CAGR of 2.9% during the forecast period.

 

Some of the significant players in the global in vitro diagnostics (IVD) market include QIAGEN N.V., Ortho Clinical Diagnostics, DiaSorin, bioMérieux, Sysmex Corporation, Bio-Rad Laboratories, Becton, Dickinson and Company, Johnson & Johnson, Thermo Fisher Scientific, Danaher Corporation, Siemens Healthineers, and Roche Diagnostics.

 

North America accounts for the largest share in the global in vitro diagnostics (IVD) market due to the presence of a robust healthcare system in the region. Furthermore, the high awareness among people in the region regarding the presence of such advanced novel technology is likely to boost the growth of the regional market.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed